Antibody After COVID-19 Vaccination

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Covid19Breakthrough InfectionCKDKidney TransplantVaccination
Interventions
BIOLOGICAL

COVID vaccine

The enrolled patients will received COVID-19 vaccine according to the vaccine protocol in Thailand ie The ChAdox-1 nCOV-19 vaccine (day 1, day 84, 12 weeks duration) or Corona vac 2 doses (day 2, day 21, 3 weeks duration) of the study. All the participants underwent blood drawn for antibody and cellular immunity measurement before the final dose of vaccination, with 7 days before first vaccine dose and eight weeks after the second doses

Trial Locations (1)

10300

Faculty of Medicine,Vajira Hospital, Bangkok

All Listed Sponsors
lead

Bangkok Metropolitan Administration Medical College and Vajira Hospital

OTHER_GOV